---
figid: PMC11079285__fonc-14-1375729-g003
figtitle: TREM2 mediated immunosuppression and regulation of cancer progression
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11079285
filename: PMC11079285__fonc-14-1375729-g003.jpg
figlink: /pmc/articles/PMC11079285/figure/F3
number: F3
caption: Overexpression of TREM2 not only inhibits CRC progression by negatively regulating
  the Wnt/ERK/GSK-3β signaling pathway, but also acts as a β-catenin regulator to
  inhibit CRC tumor progression by promoting the proteasomal degradation of β-catenin
  in the cytoplasm and negatively regulating the Wnt/β-catenin signaling pathway
papertitle: Mechanisms of TREM2 mediated immunosuppression and regulation of cancer
  progression
reftext: Xia Lei, et al. Front Oncol. 2024;14(NA).
year: '2024'
doi: 10.3389/fonc.2024.1375729
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: immune | signal pathway | cancer | mechanism | therapy
automl_pathway: 0.8599937
figid_alias: PMC11079285__F3
figtype: Figure
redirect_from: /figures/PMC11079285__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11079285__fonc-14-1375729-g003.html
  '@type': Dataset
  description: Overexpression of TREM2 not only inhibits CRC progression by negatively
    regulating the Wnt/ERK/GSK-3β signaling pathway, but also acts as a β-catenin
    regulator to inhibit CRC tumor progression by promoting the proteasomal degradation
    of β-catenin in the cytoplasm and negatively regulating the Wnt/β-catenin signaling
    pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TREM2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - GSK3B
  - GSK3A
  - EPHB2
  - MAPK1
  - MAPK3
  - Nucleus
---
